The clinical translation of regenerative-medicine products, including cell therapies,
therapeutic tissue engineering products, and human cell and tissue products, remains …

Tissue Engineering (TE) is a branch of Regenerative Medicine (RM) that combines stem
cells and biomaterial scaffolds to create living tissue constructs to restore patients' organs …

Advanced Therapy Medicinal Products (ATMPs) comprising cell, gene, and tissue-
engineered therapies have demonstrated enormous therapeutic benefits. However, their …

Advanced Therapy Medicinal Products (ATMPs) are innovative clinical treatments exploiting
the pharmacological, immunological, or metabolic properties of cells and/or gene (s) with the …

Stem cells can be defined as the cells that have the capacity to both self-renew and give rise
to differentiated cells. Under the right conditions and signals, depending on their origin and …

Regenerative medicine has emerged as a novel alternative solution to organ failure which
circumvents the issue of organ shortage. In preclinical research settings bio-artificial organs …

The introduction of new therapeutics requires validation of Good Manufacturing Practice
(GMP)-grade manufacturing including suitable quality controls. This is challenging for …

The need for advanced therapy medicinal products (ATMPs) has gained increased attention
in recent years. In this respect, a well‐designed cell expansion process is needed to …

Perinatal derivatives are drawing growing interest among the scientific community as an
unrestricted source of multipotent stromal cells, stem cells, cellular soluble mediators, and …

This paper explores how 'regenerative readiness' varies between different national research
and healthcare systems. Here,'readiness' refers to both the readiness of a given technology …